Gene · 57721
NIH grants1,078
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,078
Download this page as JSON| Grant | Title | METTL14 papers | Newest fiscal year |
|---|---|---|---|
| R01CA233671 | Role of METTL3 and the m6A Epitranscriptome in cancer | 1 | 2024 |
| R01CA237500 | Standardized Molecular Analyses of Glioma EVs | 1 | 2024 |
| R01CA238727 | Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors | 1 | 2024 |
| R01CA239078 | Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring | 1 | 2024 |
| R01CA240818 | Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy | 1 | 2024 |
| R01CA243167 | Role and mechanisms of IGF2BP1 in melanoma pathogenesis | 1 | 2024 |
| R01CA244254 | Development of ASH1L inhibitors for acute leukemia | 1 | 2024 |
| R01CA247234 | Role of Zinc Dependent EMT-Transcription Factors (EMT-TF) in Pancreatic Cancer Metastasis | 1 | 2024 |
| R01CA247550 | Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells | 1 | 2024 |
| R01CA250051 | (PQ#2) Transposable element-mediated gene regulation in KSHV-associated cancer | 1 | 2024 |
| R01CA251698 | Opposing Functions of BRD4 Isoforms in Breast Cancer | 1 | 2024 |
| R01CA253230 | Recombinant microRNAs in xenobiotic and nutrient disposition | 1 | 2024 |
| R01DK078900 | Role of Rho Kinase in Diabetic Nephropathy | 1 | 2024 |
| R01DK091310 | MicroRNA In Diabetic Nephropathy | 1 | 2024 |
| R01DK102572 | The impact of RNA chemical modifications on polycystic kidney disease progression | 1 | 2024 |
| R01DK102898 | Fibroblast Growth Factor and Energy Metabolism | 1 | 2024 |
| R01DK114220 | The role of hypothalamic Slug in the regulation of leptin sensitivity, energy balance, and body weight | 1 | 2024 |
| R01DK123079 | Unraveling the Role of NADPH Oxidase in Inflammation-associated Pancreatic Diseases | 1 | 2024 |
| R01DK126908 | Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation | 1 | 2024 |
| R01EB031957 | Programmable gene integration and cell engineering with CRISPR-directed integrases | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/grants?page=18